申请人:Balkovec M. James
公开号:US20080009504A1
公开(公告)日:2008-01-10
The present invention relates to novel enfumafungin derivatives of formula I and pharmaceutically acceptable salts thereof, their synthesis, and their use as inhibitors of (1,3)-β-D-glucan synthase. The present compounds and pharmaceutically acceptable salts thereof, as well as pharmaceutical compositions comprising the present compounds and pharmaceutically acceptable salts thereof, are useful for treating or preventing antifungal infections and associated diseases and conditions.
本发明涉及公式I的新型恩福马霉素衍生物及其药学上可接受的盐,它们的合成以及它们作为(1,3)-β-D-葡聚糖合酶抑制剂的用途。本化合物及其药学上可接受的盐,以及包括本化合物及其药学上可接受的盐的制药组合物,有用于治疗或预防抗真菌感染及相关疾病和病况的作用。